| __timestamp | Bausch Health Companies Inc. | Incyte Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 6008900000 | 508491000 |
| Thursday, January 1, 2015 | 7853800000 | 726779000 |
| Friday, January 1, 2016 | 7063000000 | 1047532000 |
| Sunday, January 1, 2017 | 6176000000 | 1456737000 |
| Monday, January 1, 2018 | 6029000000 | 1787760000 |
| Tuesday, January 1, 2019 | 6251000000 | 2044510000 |
| Wednesday, January 1, 2020 | 5778000000 | 2535374000 |
| Friday, January 1, 2021 | 6040000000 | 2835276000 |
| Saturday, January 1, 2022 | 5760000000 | 3187638000 |
| Sunday, January 1, 2023 | 6198000000 | 3440649000 |
| Monday, January 1, 2024 | 3929149000 |
Infusing magic into the data realm
In the competitive landscape of the pharmaceutical industry, Incyte Corporation and Bausch Health Companies Inc. have showcased distinct trajectories in their gross profit performance over the past decade. From 2014 to 2023, Bausch Health's gross profit has seen fluctuations, peaking in 2015 with a 30% increase from the previous year, before stabilizing around the $6 billion mark. In contrast, Incyte Corporation has demonstrated a remarkable growth trajectory, with its gross profit surging by over 575% from 2014 to 2023. This growth highlights Incyte's strategic advancements and market positioning. By 2023, Incyte's gross profit reached approximately 56% of Bausch Health's, a significant leap from just 8% in 2014. These trends underscore the dynamic nature of the industry and the varying strategies employed by these two giants.
Merck & Co., Inc. vs Incyte Corporation: A Gross Profit Performance Breakdown
Gross Profit Comparison: Merck & Co., Inc. and Bausch Health Companies Inc. Trends
Gross Profit Comparison: Gilead Sciences, Inc. and Incyte Corporation Trends
Gilead Sciences, Inc. and Bausch Health Companies Inc.: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Biogen Inc. or Incyte Corporation
United Therapeutics Corporation and Incyte Corporation: A Detailed Gross Profit Analysis
Incyte Corporation and Walgreens Boots Alliance, Inc.: A Detailed Gross Profit Analysis
Gross Profit Analysis: Comparing Incyte Corporation and Arrowhead Pharmaceuticals, Inc.
Gross Profit Comparison: Incyte Corporation and Ligand Pharmaceuticals Incorporated Trends
Incyte Corporation vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Comparing SG&A Expenses: Incyte Corporation vs Bausch Health Companies Inc. Trends and Insights
Key Insights on Gross Profit: Perrigo Company plc vs Bausch Health Companies Inc.